ALEC stock news · Alector, Inc.
Get alerts for ALEC
Follow Alector, Inc. (ALEC) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for ALECAlector, Inc. says some directors and officers are leaving, while new ones are being chosen and hired.
NeutralAlector reset staff option prices to support retention, without changing covered share counts. The lower price may help employees, but the filing reports no new research or business results.
12 health care companies are changing in price before the market opens on Monday.
NeutralAlector shares rose 56.9% before Monday's open, but the story gives no company news explaining the move. It does not change the picture of Alector's business.
Alector, Inc. has signed a big deal with Genentech worth $100 million upfront.
Good for ALECAlector gives Genentech worldwide rights to its GCase program for $100 million upfront, with more possible later. The cash and transferred work make this favorable, despite sharing future proceeds with Spur.
Alpha Buying: See where NVIDIA and Merck are putting their money.
NeutralThe article notes Merck owns Alector but provides no deal terms or commitments. That mention alone does not change how I read Alector's business prospects.